RadNet, Inc. (RDNT)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 1,072 | 1,315 | 1,430 | 1,617 | 1,830 | 2,040 | 2,269 | 2,509 |
| Operating profit | $m | 91 | 91 | ||||||
| Net profit | $m | -15 | 25 | 11 | 3 | 3 | -19 | -21 | 39 |
| EPS reported | $ | -0.25 | -0.27 | ||||||
| Operating cashflow per share | $ | 3.97 | 4.08 | ||||||
| Capex per share | $ | 2.84 | 4.83 | ||||||
| FCF per share | $ | 1.14 | -0.75 | ||||||
| Free cash flow | $m | 86 | -58 | ||||||
| Net debt | $m | 323 | 606 | ||||||
| Book value equity | $m | 1,090 | 1,096 | ||||||
| Book value per share | $ | 14.50 | 13.92 | ||||||
| Number of shares | m | 75.19 | 78.73 | ||||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | - | - | ||||||
| P/B LTM | x | 4.92 | 4.89 | ||||||
| P/S LTM | x | 2.63 | 2.36 | ||||||
| P/FCF LTM | x | 62.70 | -91.78 | ||||||
| EV/EBITDA LTM | x | 25.42 | 19.14 | ||||||
| EV/Sales LTM | x | 3.16 | 3.29 | ||||||
| Earnings Yield LTM | % | -0.35% | -0.36% | ||||||
| FCF Yield | % | +1.60% | -1.09% | ||||||
| Quality | |||||||||
| ROE | % | -1.71% | -1.95% | ||||||
| ROIC | % | +1.49% | +1.38% | ||||||
| Operating margin | % | +4.45% | +4.00% | ||||||
| Gross margin | % | +4.45% | +9.70% | ||||||
| FCF/Sales | % | +4.19% | -2.58% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | - | - | ||||||
| Sales Growth YoY | % | +11.51% | +24.01% | ||||||
| Net Income Growth YoY | % | - | - | ||||||
| FCF Growth | % | +90.35% | - | ||||||
| Operating Profit Growth | % | -13.21% | -13.17% | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.00% | 0.00% | ||||||
| Dividend Growth | % | - | - | ||||||
| Payout Ratio | % | 0.00% | 0.00% | ||||||
| FCF/Debt | x | 0.05 | -0.03 | ||||||
| Net Debt/EBITDA | x | 4.30 | 4.32 | ||||||
| EBIT/Net interest | x | 1.30 | 1.27 | ||||||
| Net debt/market cap | % | +20.32% | +22.20% | ||||||
| Net debt/Equity | x | 0.30 | 0.55 | ||||||
| Gross debt/equity | x | 1.71 | 1.99 | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
RadNet, Inc. operates as a prominent healthcare services company specializing in outpatient diagnostic imaging across the United States. Their comprehensive offerings span a broad spectrum of advanced imaging techniques, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, and general diagnostic radiology, along with various specialized procedures. Beyond direct patient services, the company also plays a significant role in developing and marketing specialized computerized systems for the diagnostic imaging sector, such as picture archiving communication systems (PACS) and associated support. Furthermore, RadNet is at the forefront of integrating artificial intelligence (AI) solutions, designing and deploying AI suites to augment radiologist interpretation, particularly in mammography, and extending these AI capabilities to lung and prostate cancer diagnostics. As of December 31, 2021, its operational footprint included ownership and management of 347 centers situated across seven states: Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Established in 1981, the company maintains its headquarters in Los Angeles, California.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
RadNet, Inc. operates as a prominent healthcare services company specializing in outpatient diagnostic imaging across the United States. Their comprehensive offerings span a broad spectrum of advanced imaging techniques, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, and general diagnostic radiology, along with various specialized procedures. Beyond direct patient services, the company also plays a significant role in developing and marketing specialized computerized systems for the diagnostic imaging sector, such as picture archiving communication systems (PACS) and associated support. Furthermore, RadNet is at the forefront of integrating artificial intelligence (AI) solutions, designing and deploying AI suites to augment radiologist interpretation, particularly in mammography, and extending these AI capabilities to lung and prostate cancer diagnostics. As of December 31, 2021, its operational footprint included ownership and management of 347 centers situated across seven states: Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Established in 1981, the company maintains its headquarters in Los Angeles, California.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free